Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Scavenger receptors on antigen-presenting cells (APCs) are a heterogeneous group of cell-surface glycoproteins that mediate the binding and uptake of various ligands, including modified lipids and pathogens [1, 2]. This specific grouping, often categorized in biological databases as 'Other scavenger receptors,' includes molecules such as CD163, Stabilin-1 (STAB1), and Stabilin-2 (STAB2) [1]. These receptors are essential for maintaining tissue homeostasis by facilitating efferocytosis, the process of clearing apoptotic cells and cellular debris [3]. Beyond clearance, they function as pattern recognition receptors that trigger or modulate signaling pathways involved in the innate immune response [2, 3]. In clinical contexts, these receptors are significant in atherosclerosis, where they contribute to lipid accumulation, and in oncology, where they are markers of immunosuppressive macrophage phenotypes [4, 5]. CD163, for example, is a well-known scavenger for hemoglobin-haptoglobin complexes and serves as a diagnostic marker for macrophage activation [4]. Stabilins are involved in the clearance of hyaluronan and are implicated in liver fibrosis and cancer metastasis [5]. Therapeutic targeting of these receptors aims to reprogram macrophage activity or block the uptake of harmful substances to treat inflammatory and metabolic disorders [1, 4].
Binding and internalization of polyanionic ligands, apoptotic cells, and hemoglobin-haptoglobin complexes to facilitate clearance and modulate immune signaling.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Scavenger receptors on antigen-presenting cells (SRs) (SRs).